China Cancer Gene Therapy Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the China Cancer Gene Therapy market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Cancer Gene Therapy market. Detailed analysis of key players, along with key growth strategies adopted by Cancer Gene Therapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Celgene

    • Bluebird bio, Inc

    • Shanghai Sunway Biotech

    • Merck

    • GlaxoSmithKline

    • Shenzhen SiBiono GeneTech

    • OncoGenex Pharmaceuticals

    • BioCancell

    • SynerGene Therapeutics

    • Adaptimmune

    By Type:

    • Ex-vivo

    • In-vivo

    By End-User:

    • Biopharma Companies

    • Research Institutes

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Gene Therapy Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Cancer Gene Therapy Market Size and Growth Rate of Ex-vivo from 2016 to 2027

    • 1.3.2 China Cancer Gene Therapy Market Size and Growth Rate of In-vivo from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Cancer Gene Therapy Market Size and Growth Rate of Biopharma Companies from 2016 to 2027

    • 1.4.2 China Cancer Gene Therapy Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • 1.4.3 China Cancer Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Cancer Gene Therapy Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Cancer Gene Therapy by Major Types

    • 3.4.1 Market Size and Growth Rate of Ex-vivo

    • 3.4.2 Market Size and Growth Rate of In-vivo

    4 Segmentation of Cancer Gene Therapy Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Cancer Gene Therapy by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Cancer Gene Therapy in Biopharma Companies

    • 4.4.2 Market Size and Growth Rate of Cancer Gene Therapy in Research Institutes

    • 4.4.3 Market Size and Growth Rate of Cancer Gene Therapy in Others

    5 Market Analysis by Regions

    • 5.1 China Cancer Gene Therapy Production Analysis by Regions

    • 5.2 China Cancer Gene Therapy Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Cancer Gene Therapy Landscape Analysis

    • 6.1 North China Cancer Gene Therapy Landscape Analysis by Major Types

    • 6.2 North China Cancer Gene Therapy Landscape Analysis by Major End-Users

    7 Central China Cancer Gene Therapy Landscape Analysis

    • 7.1 Central China Cancer Gene Therapy Landscape Analysis by Major Types

    • 7.2 Central China Cancer Gene Therapy Landscape Analysis by Major End-Users

    8 South China Cancer Gene Therapy Landscape Analysis

    • 8.1 South China Cancer Gene Therapy Landscape Analysis by Major Types

    • 8.2 South China Cancer Gene Therapy Landscape Analysis by Major End-Users

    9 East China Cancer Gene Therapy Landscape Analysis

    • 9.1 East China Cancer Gene Therapy Landscape Analysis by Major Types

    • 9.2 East China Cancer Gene Therapy Landscape Analysis by Major End-Users

    10 Northeast China Cancer Gene Therapy Landscape Analysis

    • 10.1 Northeast China Cancer Gene Therapy Landscape Analysis by Major Types

    • 10.2 Northeast China Cancer Gene Therapy Landscape Analysis by Major End-Users

    11 Southwest China Cancer Gene Therapy Landscape Analysis

    • 11.1 Southwest China Cancer Gene Therapy Landscape Analysis by Major Types

    • 11.2 Southwest China Cancer Gene Therapy Landscape Analysis by Major End-Users

    12 Northwest China Cancer Gene Therapy Landscape Analysis

    • 12.1 Northwest China Cancer Gene Therapy Landscape Analysis by Major Types

    • 12.2 Northwest China Cancer Gene Therapy Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Celgene

      • 13.1.1 Celgene Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Bluebird bio, Inc

      • 13.2.1 Bluebird bio, Inc Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Shanghai Sunway Biotech

      • 13.3.1 Shanghai Sunway Biotech Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Merck

      • 13.4.1 Merck Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 GlaxoSmithKline

      • 13.5.1 GlaxoSmithKline Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Shenzhen SiBiono GeneTech

      • 13.6.1 Shenzhen SiBiono GeneTech Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 OncoGenex Pharmaceuticals

      • 13.7.1 OncoGenex Pharmaceuticals Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 BioCancell

      • 13.8.1 BioCancell Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 SynerGene Therapeutics

      • 13.9.1 SynerGene Therapeutics Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Adaptimmune

      • 13.10.1 Adaptimmune Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Cancer Gene Therapy Market Size and Growth Rate of Ex-vivo from 2016 to 2027

    • Figure China Cancer Gene Therapy Market Size and Growth Rate of In-vivo from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Cancer Gene Therapy Market Size and Growth Rate of Biopharma Companies from 2016 to 2027

    • Figure China Cancer Gene Therapy Market Size and Growth Rate of Research Institutes from 2016 to 2027

    • Figure China Cancer Gene Therapy Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Cancer Gene Therapy Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Cancer Gene Therapy Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Cancer Gene Therapy

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Cancer Gene Therapy by Different Types from 2016 to 2027

    • Table Consumption Share of Cancer Gene Therapy by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Ex-vivo

    • Figure Market Size and Growth Rate of In-vivo

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Cancer Gene Therapy by Different End-Users from 2016 to 2027

    • Table Consumption Share of Cancer Gene Therapy by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Biopharma Companies

    • Figure Market Size and Growth Rate of Research Institutes

    • Figure Market Size and Growth Rate of Others

    • Table China Cancer Gene Therapy Production by Regions

    • Table China Cancer Gene Therapy Production Share by Regions

    • Figure China Cancer Gene Therapy Production Share by Regions in 2016

    • Figure China Cancer Gene Therapy Production Share by Regions in 2021

    • Figure China Cancer Gene Therapy Production Share by Regions in 2027

    • Table China Cancer Gene Therapy Consumption by Regions

    • Table China Cancer Gene Therapy Consumption Share by Regions

    • Figure China Cancer Gene Therapy Consumption Share by Regions in 2016

    • Figure China Cancer Gene Therapy Consumption Share by Regions in 2021

    • Figure China Cancer Gene Therapy Consumption Share by Regions in 2027

    • Table North China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table North China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure North China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure North China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure North China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table North China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table North China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure North China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure North China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure North China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table Central China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table Central China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure Central China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure Central China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure Central China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table Central China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table Central China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure Central China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure Central China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table South China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table South China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure South China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure South China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure South China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table South China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table South China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure South China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure South China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure South China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table East China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table East China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure East China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure East China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure East China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table East China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table East China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure East China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure East China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure East China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table Northeast China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table Northeast China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure Northeast China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure Northeast China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table Northeast China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table Northeast China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure Northeast China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure Northeast China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table Southwest China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table Southwest China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure Southwest China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure Southwest China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table Southwest China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table Southwest China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure Southwest China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure Southwest China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table Northwest China Cancer Gene Therapy Consumption by Types from 2016 to 2027

    • Table Northwest China Cancer Gene Therapy Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Cancer Gene Therapy Consumption Share by Types in 2016

    • Figure Northwest China Cancer Gene Therapy Consumption Share by Types in 2021

    • Figure Northwest China Cancer Gene Therapy Consumption Share by Types in 2027

    • Table Northwest China Cancer Gene Therapy Consumption by End-Users from 2016 to 2027

    • Table Northwest China Cancer Gene Therapy Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Cancer Gene Therapy Consumption Share by End-Users in 2016

    • Figure Northwest China Cancer Gene Therapy Consumption Share by End-Users in 2021

    • Figure Northwest China Cancer Gene Therapy Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Celgene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene

    • Figure Sales and Growth Rate Analysis of Celgene

    • Figure Revenue and Market Share Analysis of Celgene

    • Table Product and Service Introduction of Celgene

    • Table Company Profile and Development Status of Bluebird bio, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird bio, Inc

    • Figure Sales and Growth Rate Analysis of Bluebird bio, Inc

    • Figure Revenue and Market Share Analysis of Bluebird bio, Inc

    • Table Product and Service Introduction of Bluebird bio, Inc

    • Table Company Profile and Development Status of Shanghai Sunway Biotech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Sunway Biotech

    • Figure Sales and Growth Rate Analysis of Shanghai Sunway Biotech

    • Figure Revenue and Market Share Analysis of Shanghai Sunway Biotech

    • Table Product and Service Introduction of Shanghai Sunway Biotech

    • Table Company Profile and Development Status of Merck

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck

    • Figure Sales and Growth Rate Analysis of Merck

    • Figure Revenue and Market Share Analysis of Merck

    • Table Product and Service Introduction of Merck

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Shenzhen SiBiono GeneTech

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shenzhen SiBiono GeneTech

    • Figure Sales and Growth Rate Analysis of Shenzhen SiBiono GeneTech

    • Figure Revenue and Market Share Analysis of Shenzhen SiBiono GeneTech

    • Table Product and Service Introduction of Shenzhen SiBiono GeneTech

    • Table Company Profile and Development Status of OncoGenex Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OncoGenex Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of OncoGenex Pharmaceuticals

    • Figure Revenue and Market Share Analysis of OncoGenex Pharmaceuticals

    • Table Product and Service Introduction of OncoGenex Pharmaceuticals

    • Table Company Profile and Development Status of BioCancell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BioCancell

    • Figure Sales and Growth Rate Analysis of BioCancell

    • Figure Revenue and Market Share Analysis of BioCancell

    • Table Product and Service Introduction of BioCancell

    • Table Company Profile and Development Status of SynerGene Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SynerGene Therapeutics

    • Figure Sales and Growth Rate Analysis of SynerGene Therapeutics

    • Figure Revenue and Market Share Analysis of SynerGene Therapeutics

    • Table Product and Service Introduction of SynerGene Therapeutics

    • Table Company Profile and Development Status of Adaptimmune

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adaptimmune

    • Figure Sales and Growth Rate Analysis of Adaptimmune

    • Figure Revenue and Market Share Analysis of Adaptimmune

    • Table Product and Service Introduction of Adaptimmune


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.